baseline and follow up adherence questionnaires.
5095 final results underscore the need for TAR procedures to be placed Trizivir, given the drug's ineffectiveness.
The AACTG is the largest clinical trial research program and network of the National Institute of Health and is internationally recognized, having conducted over 3900 clinical trials for the investigation of treatments for HIV.
We also hope to receive support from the AACTG as they are federally funded.
(Adult AIDS Clinical Trials Group) 2000 Winter Meeting (Adult AIDS Clinical Trials Group), December 3-7, Arlington, Virginia http://aactg.
5095 Study Chair and Associate Professor of Medicine, Weill Medical College of Cornell University, New York.
evaluates new drugs and drug combinations for the treatment of HIV infection in adults.
REMUNE is the first investigational therapeutic vaccine to be tested by the AACTG in a pivotal clinical trial.
The AACTG is a multicenter cooperative clinical trials group funded by the Division of AIDS, National Institute of Allergy and Infectious Diseases of the National Institutes of Health.